NM HB 6: PUBLIC PEACE, HEALTH, SAFETY & WELFARE
New legislation (NM HB 6) impacts medical spas regarding supervision and scope of practice for injectables and aesthetic procedures.
Aforeworn detected this change in the Med-Spa & Aesthetics Clinics space on September 7, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Medium urgency. All medical spa operators, including nurse-owned and physician-owned clinics. should confirm how it applies to their specific situation before acting. There is a time constraint attached: Not specified.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Med-Spa & Aesthetics Clinics continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
Changes in supervision requirements and scope of practice for injectables and aesthetic procedures.
Who it affects
All medical spa operators, including nurse-owned and physician-owned clinics.
What you must do
Review and adjust operational protocols to ensure compliance with new supervision and practice scope regulations.
Deadline
Not specified.
Never miss a change like this again
Aforeworn watches Med-Spa & Aesthetics Clinics around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Med-Spa & Aesthetics Clinics
- Discover Maui's New Wave of Unique Resort Experiences - modernluxury.com
- OrangeTwist National Med‑Spa Announces Launch of Two New Non‑Surgical Skin‑Tightening Treatments, Expanding Innovation Across All 24 Centers - morningstar.com
- Samant Chauhan & Symetree Fine Jewels Redefine Luxury Retail with New Delhi Flagship - Indian Retailer
- Oak House Med Spa & Wellness Introduces the Matrix® Skin Renewal Platform: A Revolutionary Approach to Skin Health - einnews.com
- FDA Grants Accelerated Approval to a New Breast Cancer Treatment